Analysis revealed a high proportion of such cells in mesenchymal TN cell lines (94.6 % in MDA-MB-231, 86 % in SUM-159, and 69.5%% in MDA-MB-157), whereas a stem population was low represented in ER+, HER2+ or basal TN tumor cell lines, except for the basal TN line HCC-1937, in which CD44+/CD24−/low cells comprised about 29.8%% of cells (Fig. 2a).
Both values were found to be low, representing false positives for FGF19 (<145 pg/ml), in 25 out of 119 patients who had low, normal values of C4 below 28ng/mll.
Although numbers in 4 of the classes were low (representing 6.1%), these classes were chosen because they had the highest entropy (0.85) and a P-value of 0.17 for the Lo-Mendel-Rubin statistic indicating these were distinct groups.
Among these, 4 are low concentration species, representing the states of two promoters (Prop105 RNAP, PropIkBa RNAP) free and singly occupied by transcription factors FTAx, FTAz, respectively.
The frequency of micronucleated cells containing Rad51 foci induced by IDA was low and represented from 11.2% to 14.7% of the micronucleated population.
Urinary excretion ratios of TP3076 and TP3011 were low and represented at most 6% at the highest dose.
This overexpression sustained the decrease of monocytes and macrophages in bone marrow while in blood and spleen only macrophages were continuously low represented.
Despite this, seat belt wearing was low and represents one of several areas where further improvements in mortality might be realized.
Percentages were low overall, representing between 1% and 20% (median = 4.5) of blood culture isolates in eleven studies [ 10, 11, 13- 15, 18, 21, 24, 25, 27- 29].
In these patients ICU, hospital and 3-month mortality rates are comparatively low, representing a good prognosis for this subgroup of patients.
